ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value ($000): $322,433 (100.0% shares, 0.0% debt)

Holdings (19)

— QUIDEL CORP 28.8%

Value ($000) $92,932 Shares 1,903,558 Est. Cost $25223.83 Unrealized —

— AMARIN CORP PLC 22.0%

Value ($000) $70,794 Shares 5,201,580 Est. Cost $603.60 Unrealized —

— ACCELERATE DIAGNOSTICS INC 15.0%

Value ($000) $48,277 Shares 4,198,022 Est. Cost $22.30 Unrealized —

— TESARO INC 10.9%

Value ($000) $35,009 Shares 471,500 Est. Cost $12435.97 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 5.9%

Value ($000) $18,927 Shares 2,557,764 Est. Cost $4.84 Unrealized +31.0%

OPK OPKO HEALTH INC 3.4%

Value ($000) $11,095 Shares 3,686,194 Est. Cost $7.29 Unrealized -53.5%

— CONTRAFECT CORP 2.7%

Value ($000) $8,751 Shares 5,719,772 Est. Cost $2.27 Unrealized —

— MOTUS GI HLDGS INC 2.7%

Value ($000) $8,630 Shares 2,775,000 Est. Cost $3.11 Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 2.0%

Value ($000) $6,454 Shares 174,535 Est. Cost $36.98 Unrealized —

— SOLENO THERAPEUTICS INC 2.0%

Value ($000) $6,298 Shares 3,683,195 Est. Cost $1.78 Unrealized —

— BIOLASE INC 1.9%

Value ($000) $6,112 Shares 6,173,250 Est. Cost $1.21 Unrealized —

— AGENUS INC 1.0%

Value ($000) $3,234 Shares 1,358,918 Est. Cost $2.27 Unrealized —

— VERMILLION INC 0.9%

Value ($000) $2,948 Shares 9,825,289 Est. Cost $1445.80 Unrealized —

BIIB BIOGEN INC 0.6%

Value ($000) $1,926 Shares 6,368 Est. Cost $213.68 Unrealized +49.3%

— ACCELERATE DIAGNOSTICS INC 0.1%

Value ($000) $405 Shares 613,500 Est. Cost $22.30 Unrealized —

ADAPY ADAPTIMMUNE THERAPEUTICS PLC 0.1%

Value ($000) $304 Shares 52,921 Est. Cost $8.65 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 0.1%

Value ($000) $281 Shares 1,909,600 Est. Cost $4.84 Unrealized +31.0%

— QUIDEL CORP 0.0%

Value ($000) $52 Shares 144,100 Est. Cost $25223.83 Unrealized —

— AMARIN CORP PLC 0.0%

Value ($000) $4 Shares 100,000 Est. Cost $603.60 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	QUIDEL CORP	1,903,558	$92,932	28.8%	$25223.83	—	COM	74838J101
—	AMARIN CORP PLC	5,201,580	$70,794	22.0%	$603.60	—	SPONS ADR NEW	023111206
—	ACCELERATE DIAGNOSTICS INC	4,198,022	$48,277	15.0%	$22.30	—	COM	00430H102
—	TESARO INC	471,500	$35,009	10.9%	$12435.97	—	COM	881569107
PACB	PACIFIC BIOSCIENCES CALIF IN	2,557,764	$18,927	5.9%	$4.84	+31.0%	COM	69404D108
OPK	OPKO HEALTH INC	3,686,194	$11,095	3.4%	$7.29	-53.5%	COM	68375N103
—	CONTRAFECT CORP	5,719,772	$8,751	2.7%	$2.27	—	COM	212326102
—	MOTUS GI HLDGS INC	2,775,000	$8,630	2.7%	$3.11	—	COM	62014P108
—	BIOHAVEN PHARMACTL HLDG CO L	174,535	$6,454	2.0%	$36.98	—	COM	G11196105
—	SOLENO THERAPEUTICS INC	3,683,195	$6,298	2.0%	$1.78	—	COM NEW	834203200
—	BIOLASE INC	6,173,250	$6,112	1.9%	$1.21	—	COM NEW	090911207
—	AGENUS INC	1,358,918	$3,234	1.0%	$2.27	—	COM NEW	00847G705
—	VERMILLION INC	9,825,289	$2,948	0.9%	$1445.80	—	COM NEW	92407M206
BIIB	BIOGEN INC	6,368	$1,926	0.6%	$213.68	+49.3%	COM	09062X103
—	ACCELERATE DIAGNOSTICS INC	613,500	$405	0.1%	$22.30	—	Call	00430H102
ADAPY	ADAPTIMMUNE THERAPEUTICS PLC	52,921	$304	0.1%	$8.65	—	SPONDS ADR	00653A107
PACB	PACIFIC BIOSCIENCES CALIF IN	1,909,600	$281	0.1%	$4.84	+31.0%	Call	69404D108
—	QUIDEL CORP	144,100	$52	0.0%	$25223.83	—	Call	74838J101
—	AMARIN CORP PLC	100,000	$4	0.0%	$603.60	—	Call	023111206